| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.00088 | 1 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.0007 | 1 |